Cardiovascular stability and unchanged muscle sympathetic activity during xenon anaesthesia: Role of norepinephrine uptake inhibition

British Journal of Anaesthesia

Volumn 109, Issue 6, 2012, Pages 887-896

  Neukirchen, M ^a   Hipp, J ^a   Schaefer, M S ^a   Brandenburger, T ^a   Bauer, I ^a   Winterhalter, M ^a   Kienbaum, P ^a   Werdehausen, R ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

adrenergic regulation; autonomic nervous system; norepinephrine; sympathetic activity; xenon anaesthesia

Indexed keywords

3H NOREPINEPHRINE; DIZOCILPINE; GLYCINE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NORADRENALIN; NORADRENALIN TRANSPORTER; UNCLASSIFIED DRUG; XENON;

ARTERIAL PRESSURE; ARTICLE; BLOOD GAS ANALYSIS; CARDIOVASCULAR FUNCTION; CELL LINE; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; MUSCLE CONTRACTION; MUSCLE SYMPATHETIC ACTIVITY; NEUROGRAPHY; NORADRENALIN BLOOD LEVEL; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REFLEX; SYMPATHETIC BAROREFLEX GAIN;

EID: 84869443142     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aes303     Document Type: Article

References (43)

1. Monk TG, Saini V, Weldon BC, Sigl JC. Anesthetic management and one-year mortality after noncardiac surgery. Anesth Analg 2005; 100: 4-10 (Pubitemid 40013594)
2. Kheterpal S, O'Reilly M, Englesbe MJ, et al. Preoperative and intraoperative predictors of cardiac adverse events after general, vascular, and urological surgery. Anesthesiology 2009; 110: 58-66
3. Bijker JB, van Klei WA, Vergouwe Y, et al. Intraoperative hypotension and 1-year mortality after noncardiac surgery. Anesthesiology 2009; 111: 1217-26
4. Neukirchen M, Kienbaum P. Sympathetic nervous system: Evaluation and importance for clinical general anesthesia. Anesthesiology 2008; 109: 1113-31
5. Wappler F, Rossaint R, Baumert J, et al. Multicenter randomized comparison of xenon and isoflurane on left ventricular function in patients undergoing elective surgery. Anesthesiology 2007; 106: 463-71 (Pubitemid 46662211)
6. Baumert JH, Hein M, Hecker KE, Satlow S, Schnoor J, Rossaint R. Autonomic cardiac control with xenon anaesthesia in patients at cardiovascular risk. Br J Anaesth 2007; 98: 722-7 (Pubitemid 47072580)
7. Baily RG, Prophet SA, Shenberger JS, Zelis R, Sinoway LI. Direct neurohumoral evidence for isolated sympathetic nervous system activation to skeletal muscle in response to cardiopulmonary baroreceptor unloading. Circ Res 1990; 66: 1720-8 (Pubitemid 20178720)
8. Vissing SF, Scherrer U, Victor RG. Relation between sympathetic outflow and vascular resistance in the calf during perturbations in central venous pressure. Evidence for cardiopulmonary afferent regulation of calf vascular resistance in humans. Circ Res 1989; 65: 1710-7 (Pubitemid 20023564)
9. Wallin BG, Esler M, Dorward P, et al. Simultaneous measurements of cardiac noradrenaline spillover and sympathetic outflow to skeletal muscle in humans. J Physiol 1992; 453: 45-58
10. Wallin BG, Thompson JM, Jennings GL, Esler MD. Renal noradrenaline spillover correlates with muscle sympathetic activity in humans. J Physiol 1996; 491 (Pt 3): 881-7 (Pubitemid 26107257)
11. Sundlof G, Wallin BG. The variability of muscle nerve sympathetic activity in resting recumbent man. J Physiol 1977; 272: 383-97 (Pubitemid 8200922)
12. Kienbaum P, Heuter T, Michel MC, Scherbaum N, Gastpar M, Peters J. Chronic mu-opioid receptor stimulation in humans decreases muscle sympathetic nerve activity. Circulation 2001; 103: 850-5 (Pubitemid 32163884)
13. Kienbaum P, Heuter T, Michel MC, Peters J. Racemic ketamine decreases muscle sympathetic activity but maintains the neural response to hypotensive challenges in humans. Anesthesiology 2000; 92: 94-101 (Pubitemid 30027452)
14. Kienbaum P, Peters J. Muscle sympathetic baroreflex sensitivity is different at rest and during evoked hypotension. Basic Res Cardiol 2004; 99: 152-8
15. Scholze P, Norregaard L, Singer EA, Freissmuth M, Gether U, Sitte HH. The role of zinc ions in reverse transport mediated by monoamine transporters. J Biol Chem 2002; 277: 21505-13 (Pubitemid 34952294)
16. Biedler JL, Roffler-Tarlov S, Schachner M, Freedman LS. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res 1978; 38: 3751-7 (Pubitemid 9045201)
17. Werdehausen R, Kremer D, Brandenburger T, et al. Lidocaine metabolites inhibit glycine transporter 1: A novel mechanism for the analgesic action of systemic lidocaine? Anesthesiology 2012; 116: 1147-58
18. Hara K, Yanagihara N, Minami K, et al. Ketamine interacts with the noradrenaline transporter at a site partly overlapping the desipramine binding site. Naunyn Schmiedebergs Arch Pharmacol 1998; 358: 328-33 (Pubitemid 28425489)
19. Nishimura M, Sato K, Okada T, et al. Ketamine inhibits monoamine transporters expressed in human embryonic kidney 293 cells. Anesthesiology 1998; 88: 768-74 (Pubitemid 28120212)
20. Weber NC, Kandler J, Schlack W, Grueber Y, Fradorf J, Preckel B. Intermitted pharmacologic pretreatment by xenon, isoflurane, nitrous oxide, and the opioid morphine prevents tumor necrosis factor alpha-induced adhesion molecule expression in human umbilical vein endothelial cells. Anesthesiology 2008; 108: 199-207 (Pubitemid 351156729)
21. Whone AL, Kemp K, Sun M, Wilkins A, Scolding NJ. Human bone marrow mesenchymal stem cells protect catecholaminergic and serotonergic neuronal perikarya and transporter function from oxidative stress by the secretion of glial-derived neurotrophic factor. Brain Res 2012; 1431: 86-96
22. Esler M, Jennings G, Leonard P, et al. Contribution of individual organs to total noradrenaline release in humans. Acta Physiol Scand Suppl 1984; 527: 11-6 (Pubitemid 14105699)
23. Eisenhofer G, Kopin IJ, Goldstein DS. Catecholamine metabolism: A contemporary view with implications for physiology and medicine. Pharmacol Rev 2004; 56: 331-49 (Pubitemid 39096594)
24. Shannon JR, Flattem NL, Jordan J, et al. Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N Engl J Med 2000; 342: 541-9 (Pubitemid 30117894)
25. Iber T, Hecker K, Vagts DA, et al. Xenon anesthesia impairs hepatic oxygenation and perfusion in healthy pigs. Minerva Anestesiol 2008; 74: 511-9
26. Yoshida H, Kushikata T, Tose R, Kudo M, Kudo T, Hirota K. Nitrous oxide and xenon increase noradrenaline release in the cerebral cortex in vivo and in vitro. Neurosci Lett 2010; 469: 199-203
27. Lambert GW, Kaye DM, Thompson JM, et al. Internal jugular venous spillover of noradrenaline and metabolites and their association with sympathetic nervous activity. Acta Physiol Scand 1998; 163: 155-63 (Pubitemid 28270901)
28. Sanders RD, Franks NP, Maze M. Xenon: No stranger to anaesthesia. Br J Anaesth 2003; 91: 709-17 (Pubitemid 37369533)
29. Dickinson R, Peterson BK, Banks P, et al. Competitive inhibition at the glycine site of the N-methyl-D-aspartate receptor by the anesthetics xenon and isoflurane: Evidence from molecular modeling and electrophysiology. Anesthesiology 2007; 107: 756-67 (Pubitemid 351325968)
30. Haseneder R, Kratzer S, Kochs E, Eckle VS, Zieglgansberger W, Rammes G. Xenon reduces N-methyl-D-aspartate and alphaamino-3-hydroxy-5-methyl-4- isoxazolepropionic acid receptormediated synaptic transmission in the amygdala. Anesthesiology 2008; 109: 998-1006
31. Anis NA, Berry SC, Burton NR, Lodge D. The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. Br J Pharmacol 1983; 79: 565-75 (Pubitemid 13055426)
32. Lundy PM, Lockwood PA, Thompson G, Frew R. Differential effects of ketamine isomers on neuronal and extraneuronal catecholamine uptake mechanisms. Anesthesiology 1986; 64: 359-63 (Pubitemid 16155866)
33. Baumert JH, Falter F, Eletr D, Hecker KE, Reyle-Hahn M, Rossaint R. Xenon anaesthesia may preserve cardiovascular function in patients with heart failure. Acta Anaesthesiol Scand 2005; 49: 743-9
34. Boomsma F, Rupreht J, Man in 't Veld AJ, de Jong FH, Dzoljic M, Lachmann B. Haemodynamic and neurohumoral effects of xenon anaesthesia. A comparison with nitrous oxide. Anaesthesia 1990; 45: 273-8 (Pubitemid 20147351)
35. Francis RC, Reyle-Hahn MS, Hohne C, et al. The haemodynamic and catecholamine response to xenon/remifentanil anaesthesia in Beagle dogs. Lab Anim 2008; 42: 338-49 (Pubitemid 352029863)
36. Maze M, TranquilliW. Alpha-2 adrenoceptor agonists: Defining the role in clinical anesthesia. Anesthesiology 1991; 74: 581-605
37. Pertovaara A. Noradrenergic pain modulation. Prog Neurobiol 2006; 80: 53-83 (Pubitemid 44692016)
38. Tose R, Kushikata T, Yoshida H, et al. Interaction between orexinergic neurons and NMDA receptors in the control of locus coeruleus-cerebrocortical noradrenergic activity of the rat. Brain Res 2009; 1250: 81-7
39. Scheeren TW, Arndt JO. Different response of oxygen consumption and cardiac output to various endogenous and synthetic catecholamines in awake dogs. Crit Care Med 2000; 28: 3861-8 (Pubitemid 32044485)
40. Rex S, Schaefer W, Meyer PH, et al. Positron emission tomography study of regional cerebral metabolism during general anesthesia with xenon in humans. Anesthesiology 2006; 105: 936-43 (Pubitemid 44655504)
41. Frö lich MA, Dennis DM, Shuster JA, Melker RJ. Precision and bias of target controlled propofol infusion for sedation. Br J Anaesth 2005; 94: 434-7
42. Sellgren J, Ejnell H, Elam M, Ponte'n J, Wallin BG. Sympathetic muscle nerve activity, peripheral blood flows, and baroreceptor reflexes in humans during propofol anesthesia and surgery. Anesthesiology 1994; 80: 534-44 (Pubitemid 24097684)
43. Wallin BG, Hart EC, Wehrwein EA, Charkoudian N, Joyner MJ. Relationship between breathing and cardiovascular function at rest: sex-related differences. Acta Physiol (Oxf) 2010; 200: 193-200